T1	Disorder 10 29	Infectious toxicity
T2	Pharmacological_substance 33 46	dexamethasone
N1000 	Reference T2 MeSH:D003907	dexamethasone
T3	Disorder 165 193	acute lymphoblastic leukemia
N1 	Reference T3 UMLS:C0023449	acute lymphoblastic leukemia
T4	Pharmacological_substance 202 212	prednisone
N1001 	Reference T4 MeSH:D011241	prednisone
T5	Pharmacological_substance 308 321	dexamethasone
N1002 	Reference T5 MeSH:D003907	dexamethasone
T6	Pharmacological_substance 333 343	prednisone
N1003 	Reference T6 MeSH:D011241	prednisone
T7	Disorder 378 399	infectious toxicities
T8	Pharmacological_substance 470 483	dexamethasone
N1004 	Reference T8 MeSH:D003907	dexamethasone
T10	Pharmacological_substance 569 582	dexamethasone
N1005 	Reference T10 MeSH:D003907	dexamethasone
T11	Disorder 669 693	infectious complications
N2 	Reference T11 UMLS:C0275524	infectious complications
N3 	Reference T11 UMLS:C0275524	infectious complications
T12	Pharmacological_substance 699 712	dexamethasone
N1006 	Reference T12 MeSH:D003907	dexamethasone
T14	Pharmacological_substance 745 758	dexamethasone
N1007 	Reference T14 MeSH:D003907	dexamethasone
T16	Pharmacological_substance 849 862	dexamethasone
N1008 	Reference T16 MeSH:D003907	dexamethasone
T17	Disorder 923 931	toxicity
N4 	Reference T17 UMLS:C0600688	toxicity
T15	Subject 151 159	children
T20	Subject 425 437	two patients
T21	Combination 225 235	multiagent
T22	Pharmacological_substance 256 268	chemotherapy
N1009 	Reference T22 MeSH:C403362	chemotherapy
N1010 	Reference T22 MeSH:D004113	chemotherapy
N1011 	Reference T22 MeSH:C057647	chemotherapy
T24	Speculation_cue 661 665	risk
T27	Pharmacological_substance 78 90	chemotherapy
N1012 	Reference T27 MeSH:C403362	chemotherapy
N1013 	Reference T27 MeSH:D004113	chemotherapy
N1014 	Reference T27 MeSH:C057647	chemotherapy
